BCL2 mRNA or Protein Abundance Is Superior to Gene Rearrangement Status in Predicting Clinical Outcomes in Patients With Diffuse Large B-Cell Lymphoma

Hematological Oncology - United Kingdom
doi 10.1002/hon.2439_17
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Clinical Significance and Outcomes in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) Harboring Extra Copies [Ec] and/or Translocations [Tl] of Myc, Bcl2, and Bcl6

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Outcome of Patients With C-Myc Rearranged Diffuse Large B Cell Lymphoma Associated or Not With Bcl2 and/or Bcl6 Rearrangement: A Multicentric and Retrospective Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Clinical Significance of T-Cell Exhaustion in Patients With Diffuse Large B-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Increased MYC Gene Copy Number Correlates With Increased mRNA Levels in Diffuse Large B-Cell Lymphoma

Haematologica
Hematology
2010English

KLHL6 Is a Tumor Suppressor Gene in Diffuse Large B-Cell Lymphoma

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2019English

BCL-2 Protein Frequency in Patients With High-Risk Diffuse Large B-Cell Lymphoma

Sao Paulo Medical Journal
Medicine
2010English

R-Chop With or Without Bevacizumab in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma: Final MAIN Study Outcomes

Haematologica
Hematology
2014English

The Distinction Between Burkitt Lymphoma and Diffuse Large B-Cell Lymphoma With C-Myc Rearrangement

Modern Pathology
Forensic MedicinePathology
2002English

Immunochemoradiotherapy or Immunochemotherapy Only in Patients With Extranonal Diffuse Large B-Cell Lymphoma of Stomach

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy